NEW YORK (GenomeWeb News) — Compendia Bioscience yesterday said it has won a $2.4-million SBIR Fast Track Award from the National Cancer Institute to help it further develop its Oncomine Professional technology.
Oncomine, designed for biomarker and therapeutic target discovery, validation, and prioritization, combines more than 20,000 cancer transcriptome profiles with an analysis engine and a web application to mine and visualize data, Compendia said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.